Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody
Abstract Heart failure is the terminal stage of many cardiac diseases, in which β1-adrenoceptor (β1-AR) autoantibody (β1-AA) has a causative role. By continuously activating β1-AR, β1-AA can induce cytotoxicity, leading to cardiomyocyte apoptosis and heart dysfunction. However, the mechanism underly...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bd0e293fbd745609331d73aadadb01c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8bd0e293fbd745609331d73aadadb01c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8bd0e293fbd745609331d73aadadb01c2021-11-14T12:12:37ZBiased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody10.1038/s41420-021-00735-22058-7716https://doaj.org/article/8bd0e293fbd745609331d73aadadb01c2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41420-021-00735-2https://doaj.org/toc/2058-7716Abstract Heart failure is the terminal stage of many cardiac diseases, in which β1-adrenoceptor (β1-AR) autoantibody (β1-AA) has a causative role. By continuously activating β1-AR, β1-AA can induce cytotoxicity, leading to cardiomyocyte apoptosis and heart dysfunction. However, the mechanism underlying the persistent activation of β1-AR by β1-AA is not fully understood. Receptor endocytosis has a critical role in terminating signals over time. β2-adrenoceptor (β2-AR) is involved in the regulation of β1-AR signaling. This research aimed to clarify the mechanism of the β1-AA-induced sustained activation of β1-AR and explore the role of the β2-AR/Gi-signaling pathway in this process. The beating frequency of neonatal rat cardiomyocytes, cyclic adenosine monophosphate content, and intracellular Ca2+ levels were examined to detect the activation of β1-AA. Total internal reflection fluorescence microscopy was used to detect the endocytosis of β1-AR. ICI118551 was used to assess β2-AR/Gi function in β1-AR sustained activation induced by β1-AA in vitro and in vivo. Monoclonal β1-AA derived from a mouse hybridoma could continuously activate β1-AR. β1-AA-restricted β1-AR endocytosis, which was reversed by overexpressing the endocytosis scaffold protein β-arrestin1/2, resulting in the cessation of β1-AR signaling. β2-AR could promote β1-AR endocytosis, as demonstrated by overexpressing/interfering with β2-AR in HL-1 cells, whereas β1-AA inhibited the binding of β2-AR to β1-AR, as determined by surface plasmon resonance. ICI118551 biasedly activated the β2-AR/Gi/G protein-coupled receptor kinase 2 (GRK2) pathway, leading to the arrest of limited endocytosis and continuous activation of β1-AR by β1-AA in vitro. In vivo, ICI118551 treatment attenuated myocardial fiber rupture and left ventricular dysfunction in β1-AA-positive mice. This study showed that β1-AA continuously activated β1-AR by inhibiting receptor endocytosis. Biased activation of the β2-AR/Gi/GRK2 signaling pathway could promote β1-AR endocytosis restricted by β1-AA, terminate signal transduction, and alleviate heart damage.Hao ChenNing CaoLi WangYe WuHaojie WeiYuming LiYouyi ZhangSuli ZhangHuirong LiuNature Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282CytologyQH573-671ENCell Death Discovery, Vol 7, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Cytology QH573-671 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Cytology QH573-671 Hao Chen Ning Cao Li Wang Ye Wu Haojie Wei Yuming Li Youyi Zhang Suli Zhang Huirong Liu Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
description |
Abstract Heart failure is the terminal stage of many cardiac diseases, in which β1-adrenoceptor (β1-AR) autoantibody (β1-AA) has a causative role. By continuously activating β1-AR, β1-AA can induce cytotoxicity, leading to cardiomyocyte apoptosis and heart dysfunction. However, the mechanism underlying the persistent activation of β1-AR by β1-AA is not fully understood. Receptor endocytosis has a critical role in terminating signals over time. β2-adrenoceptor (β2-AR) is involved in the regulation of β1-AR signaling. This research aimed to clarify the mechanism of the β1-AA-induced sustained activation of β1-AR and explore the role of the β2-AR/Gi-signaling pathway in this process. The beating frequency of neonatal rat cardiomyocytes, cyclic adenosine monophosphate content, and intracellular Ca2+ levels were examined to detect the activation of β1-AA. Total internal reflection fluorescence microscopy was used to detect the endocytosis of β1-AR. ICI118551 was used to assess β2-AR/Gi function in β1-AR sustained activation induced by β1-AA in vitro and in vivo. Monoclonal β1-AA derived from a mouse hybridoma could continuously activate β1-AR. β1-AA-restricted β1-AR endocytosis, which was reversed by overexpressing the endocytosis scaffold protein β-arrestin1/2, resulting in the cessation of β1-AR signaling. β2-AR could promote β1-AR endocytosis, as demonstrated by overexpressing/interfering with β2-AR in HL-1 cells, whereas β1-AA inhibited the binding of β2-AR to β1-AR, as determined by surface plasmon resonance. ICI118551 biasedly activated the β2-AR/Gi/G protein-coupled receptor kinase 2 (GRK2) pathway, leading to the arrest of limited endocytosis and continuous activation of β1-AR by β1-AA in vitro. In vivo, ICI118551 treatment attenuated myocardial fiber rupture and left ventricular dysfunction in β1-AA-positive mice. This study showed that β1-AA continuously activated β1-AR by inhibiting receptor endocytosis. Biased activation of the β2-AR/Gi/GRK2 signaling pathway could promote β1-AR endocytosis restricted by β1-AA, terminate signal transduction, and alleviate heart damage. |
format |
article |
author |
Hao Chen Ning Cao Li Wang Ye Wu Haojie Wei Yuming Li Youyi Zhang Suli Zhang Huirong Liu |
author_facet |
Hao Chen Ning Cao Li Wang Ye Wu Haojie Wei Yuming Li Youyi Zhang Suli Zhang Huirong Liu |
author_sort |
Hao Chen |
title |
Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
title_short |
Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
title_full |
Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
title_fullStr |
Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
title_full_unstemmed |
Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody |
title_sort |
biased activation of β2-ar/gi/grk2 signal pathway attenuated β1-ar sustained activation induced by β1-adrenergic receptor autoantibody |
publisher |
Nature Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/8bd0e293fbd745609331d73aadadb01c |
work_keys_str_mv |
AT haochen biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT ningcao biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT liwang biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT yewu biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT haojiewei biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT yumingli biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT youyizhang biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT sulizhang biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody AT huirongliu biasedactivationofb2argigrk2signalpathwayattenuatedb1arsustainedactivationinducedbyb1adrenergicreceptorautoantibody |
_version_ |
1718429358647934976 |